FRONTIER5: Safety and patient experience of a direct switch from emicizumab to denecimig (Mim8) in patients with haemophilia A with or without inhibitors.
Journal of thrombosis and haemostasis : JTH
View this publicationJournal of thrombosis and haemostasis : JTH
View this publicationHamostaseologie
View this publicationNature communications
View this publicationRadiology
View this publicationTH open : companion journal to thrombosis and haemostasis
View this publicationBlood advances
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationScientific reports
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publication